Boston Scientific Corporation (BSX) Comparison with companies in other sectors?

Boston Scientific Corporation has a share price of 1.48B. You can analyze Boston Scientific Corporation (BSX) competitors across different market sectors through stock heatmaps.

What are BSX's NET and operating margins?

Boston Scientific Corporation (BSX) operating margin is around 0.18, and net profit margin is approximately 0.12 as of the latest reports.

In what way does BSX's earnings per share (EPS) trend reflect its financial momentum?

Boston Scientific Corporation (BSX) EPS is 1.37 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Boston Scientific Corporation is 75.77, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Boston Scientific Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Boston Scientific Corporation like P/E which is 75.71, P/B which is 6.93, and PEG which is 7.95. Compare them with sector averages to evaluate if the stock is priced fairly.

Boston Scientific Corporation

BSX•NYSE

Healthcare

Medical - Devices

$103.72

$0.08(0.08%)

Fundamental Analysis of Boston Scientific Corporation (BSX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$1.37

P/E Ratio

75.77

ROE

0.10%

Net Margin

0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$153.58B

Shares OutstandingTotal number of shares issued

$1.48B

Book Value/ShareNet worth per share

$15.19

Revenue/ShareAnnual revenue per share

$11.88

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$1.37

Net MarginNet income as percentage of revenue

11.58%

Operating MarginOperating income as percentage of revenue

17.52%

ROEReturn on shareholders' equity

9.56%

ROAReturn on total assets

5.06%

ROCEReturn on capital employed

8.77%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.94

Cash/ShareCash and equivalents per share

$0.49

FCF YieldFree cash flow as percentage of market cap

1.87%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for BSXFinancial Ratios Analysis details for BSX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BSXSector Benchmarking details for BSX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Boston Scientific Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Boston Scientific Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Boston Scientific Corporation's unique business strengths and challenges.

Key Financial Metrics for Boston Scientific Corporation

For Boston Scientific Corporation, essential financial indicators include EPS 1.37, PE 75.77, and ROE 0.10. These key ratios reveal insights into Boston Scientific Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare Boston Scientific Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Boston Scientific Corporation

Metrics like Net Margin 11.58% and ROA 5.06% shed light on how well Boston Scientific Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Boston Scientific Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of Boston Scientific Corporation

Using ratios such as P/B Ratio 6.93 and PEG Ratio 7.95, investors can assess whether Boston Scientific Corporation is appropriately valued based on its financials and growth potential. These figures, combined with Boston Scientific Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Boston Scientific Corporation

Financial health indicators, such as Debt/Equity Ratio 0.53 and Cash Flow $1.94, provide a snapshot of Boston Scientific Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Boston Scientific Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Boston Scientific Corporation

Investing in Boston Scientific Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Boston Scientific Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;